SCHEMBL7001855

SCHEMBL7001855

O=C1OCc2cccc(O)c21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.53
ALDH1A1 P00352 5/20 0.53
HSD17B10 Q99714 4/20 0.53
ALOX15 P16050 3/20 0.53
TDP1 Q9NUW8 3/20 0.53
USP2 O75604 3/20 0.53
KMT2A Q03164 3/20 0.53
TSHR P16473 2/20 0.53
MEN1 O00255 2/20 0.53
CYP3A4 P08684 2/20 0.53
THRB P10828 2/20 0.53
HPN P05981 1/20 0.53
ALOX5 P09917 1/20 0.53
PTGS1 P23219 1/20 0.53
PDE4A P27815 1/20 0.53
KDR P35968 1/20 0.53
SIRT5 Q9NXA8 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
HRH3 Q9Y5N1 1/20 0.53
MAOA P21397 6/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9959163 0.80 MAOA (0.53) MAPTALDH1A1HSD17B10ALOX15TDP1
SCHEMBL29448274 0.78 KDM4E (0.57) MAPTALDH1A1HSD17B10ALOX15TDP1
SCHEMBL15509594 0.78 KDM4E (0.57) MAPTALDH1A1HSD17B10ALOX15TDP1
SCHEMBL15680616 0.78 KDM4E (0.46) MAPTALDH1A1HSD17B10ALOX15TDP1
SCHEMBL24354167 0.77 MAOA (0.52) MAPTALDH1A1HSD17B10ALOX15TDP1
SCHEMBL20652853 0.76 MAOA (0.50) MAPTALDH1A1HSD17B10ALOX15TDP1
SCHEMBL4455687 0.75 KDM4E (0.47) MAPTALDH1A1HSD17B10TDP1KDR
SCHEMBL1611599 0.75 MAOA (0.47) MAPTALDH1A1HSD17B10KMT2AMEN1
SCHEMBL32672790 0.75 TDP2 (0.50) MAPTALDH1A1HSD17B10ALOX15TDP1
SCHEMBL855553 0.75 MAOA (0.47) MAPTALDH1A1HSD17B10ALOX5L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220386582-A1 METHOD AND DEVICE TO TRAP ACARIDS DOMOBIOS (BE) 2022-12-08 US disclosed
CN-113413439-B Traditional Chinese medicine formula for treating Alzheimer's disease and preparation method of compound preparation of traditional Chinese medicine formula 中山创天生物科技有限公司 2022-03-29 CN disclosed
US-20210161130-A1 COMPOSITIONS FOR ATTRACTING PESTS AND USES THEREOF DOMOBIOS (BE) 2021-06-03 US disclosed
EP-3813530-A1 COMPOSITIONS FOR ATTRACTING PESTS AND USES THEREOF Domobios (BE) 2021-05-05 EP disclosed
US-20200344991-A1 METHOD AND DEVICE TO TRAP ACARIDS DOMOBIOS (BE) 2020-11-05 US disclosed
EP-3253203-B1 METHOD AND DEVICE TO TRAP ACARIDS DOMOBIOS (BE) 2020-10-28 EP disclosed
WO-2020162471-A1 PYRIDONE DERIVATIVE マルホ株式会社 2020-08-13 WO disclosed
US-20180027793-A1 METHOD AND DEVICE TO TRAP ACARIDS DOMOBIOS (BE) 2018-02-01 US disclosed
WO-2018010332-A1 MEDICAL USE OF 7-HYDROXY-BUTYLPHTHALIDE 华北制药集团新药研究开发有限责任公司 2018-01-18 WO disclosed
US-20170273981-A1 HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS GLAXOSMITHKLINE S.P.A. (IT) 2017-09-28 US disclosed
US-6465660-B1 PARTICULARLY 2-HYDROXY-8,9-DIMETHOXYISOINDOLO(2,1-A)INDOL-6-ONE AND 2-HYDROXY-8,9-DIMETHOXYISOINDOLO(2,1-A)INDOL-6-ONE; TREATING A DISORDER OF THE MELATONINERGIC SYSTEM LES LABORATOIRES SERVIER (FR) 2002-10-15 US disclosed
EP-1241169-A1 Isoindoloindolone derivatives, process for their preparation and pharmaceutical compositions containing them Les Laboratoires Servier (FR) 2002-09-18 EP disclosed
US-5428002-A Herbicides CIBA-GEIGY CORPORATION (US) 1995-06-27 US disclosed
EP-0447506-B1 PYRIMIDINE AND TRIAZINE DERIVATIVES WITH HERBICIDAL AND PLANT GROWTH REGULATING PROPERTIES CIBA GEIGY AG (CH) 1994-10-26 EP disclosed
US-5332717-A Herbicides, plant growth regulators CIBA-GEIGY CORPORATION (US) 1994-07-26 US disclosed
US-5254595-A Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them ELF SANOFI (FR) 1993-10-19 US disclosed
EP-0375560-B1 ARYLOXYPROPANOLAMINOTETRALINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME ELF SANOFI (FR) 1993-05-12 EP disclosed
EP-0447506-A1 PYRIMIDINE AND TRIAZINE DERIVATIVES WITH HERBICIDAL AND PLANT GROWTH REGULATING PROPERTIES. MAAG AG R (CH) 1991-09-25 EP disclosed
WO-1991005781-A1 PYRIMIDINE AND TRIAZINE DERIVATIVES WITH HERBICIDAL AND PLANT GROWTH REGULATING PROPERTIES DR. R. MAAG AG (CH) 1991-05-02 WO disclosed
EP-0375560-A1 Aryloxypropanolaminotetralines, process for their preparation and pharmaceutical compositions containing same ELF SANOFI (FR) 1990-06-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170273981-A1 HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS KCNA3, KCND3, KCNN3 MAPT 3971/4885ALDH1A1 1789/4885HSD17B10 2091/4885
US-20210161130-A1 COMPOSITIONS FOR ATTRACTING PESTS AND USES THEREOF ACAT1, ATL3, NISCH MAPT 215/4885ALDH1A1 2159/4885HSD17B10 1752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.